Filter
1197
Filtered Results: 1197
Text search:
comorbidity
Featured
Recommendations
123
New Publications
177
Language
Document type
No document type
533
Guidelines
255
Studies & Reports
241
Strategic & Response Plan
52
Manuals
45
Fact sheets
35
Training Material
13
Situation Updates
11
Infographics
8
Resource Platforms
3
Online Courses
1
Countries / Regions
Global
82
India
59
Latin America and the Carribbean
35
South Africa
32
Western and Central Europe
29
Kenya
27
Africa
25
Brazil
17
Ukraine
14
Malawi
11
West and Central Africa
11
Eastern Europe
11
Russia
11
Syria
10
South–East Asia Region
10
Sierra Leone
9
Nigeria
9
Asia
9
Tanzania
9
Middle East and North Africa
9
Nepal
8
East and Southern Africa
8
Uganda
8
Ethiopia
8
Liberia
8
Mozambique
7
Germany
7
Congo, Democratic Republic of
7
Colombia
6
Rwanda
6
Senegal
6
Peru
6
Bangladesh
6
Zambia
6
Ghana
5
Cameroon
5
Philippines
5
Namibia
5
Myanmar / Burma
5
Chile
4
Zimbabwe
4
Cambodia
4
Western Pacific Region
4
Angola
4
Indonesia
4
Tajikistan
3
Lesotho
3
Burkina Faso
3
USA
3
Eastern Europe and Central Asia
3
Bolivia
3
Ecuador
3
Eswatini/ Swaziland
3
Laos
2
Guinea
2
Venezuela
2
United Kingdom
2
Argentina
2
Lebanon
2
Vietnam
2
Egypt
2
Central African Republic
2
Iraq
2
Thailand
1
Mexico
1
Turkey
1
Benin
1
Togo
1
China
1
Iran
1
Canada
1
Singapore
1
Estonia
1
Congo-Brazzaville
1
Italy
1
Haiti
1
Guinea-Bissau
1
Jordan
1
Ireland
1
North America
1
Gabon
1
Jamaica
1
France
1
Mauritius
1
Portugal
1
Belarus
1
Moldova
1
Romania
1
Palestine
1
Georgia
1
Chad
1
Botswana
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
339
Clinical Guidelines
132
Public Health
87
Women & Child Health
17
Key Resources
9
Capacity Building
7
Pharmacy & Technologies
2
Toolboxes
Mental Health
280
COVID-19
227
TB
120
HIV
105
NCDs
83
AMR
29
Disability
24
Caregiver
24
NTDs
21
Pharmacy
15
Conflict
15
Rapid Response
14
Refugee
13
Ebola
9
Cholera
8
Planetary Health
6
Health Financing Toolbox
6
Polio
4
Global Health Education
4
Natural Hazards
3
Social Ethics
1
Zika
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Previous advocacy efforts have achieved tangible goals in terms garnering political commitments
to increase financing for TB—as seen at the 2018 UN High-Level Meeting on TB. The challenge
now is to ensure that these commitments are actually met within a global biomedical research
ecosystem that...
The response to a cholera outbreak must focus on limiting mortality and reducing the spread of the disease. It should be comprehensive and multisectoral, including epidemiology, case management, water, sanitation and hygiene, logistics, community engagement and risk communication. All efforts must b...
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
Today, the World Health Organization (WHO) is advancing the global fight against acute malnutrition in children under 5 with the launch of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition). This milestone is a crucial response to the persistent...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Peripheral artery disease (PAD) is the most underdiagnosed, underestimated and undertreated of the atherosclerotic vascular diseases despite its poor prognosis. There may be racial or contextual differences in the Asia-Pacific region as to epidemiology, availability of diagnostic and therapeutic mod...
Background
Chronic congestive heart failure is a common condition that, if untreated, markedly impairs the quality of life and is associated with a high risk of recurrent hospitalization and death.
Methods
This review is based on articles retrieved by a selective search in PubMed, as well as on r...
